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Abstract
The epidermal growth factor receptor is involved in morphogenesis, proliferation and cell migration. Its up-regulation
during tumorigenesis makes this receptor an interesting therapeutic target. In the absence of the ligand, the inhibition
of phosphatidic acid phosphohydrolase activity by propranolol treatment leads to internalization of empty/inactive
receptors. The molecular events involved in this endocytosis remain unknown. Here, we quantified the effects of
propranolol on the mobility of single quantum-dot labelled receptors before the actual internalization took place. The
single receptors showed a clear stop-and-go motion; their diffusive tracks were continuously interrupted by sub-
second stalling events, presumably caused by transient clustering. In the presence of propranolol we found that: i)
the diffusion rate reduced by 22 %, which indicates an increase in drag of the receptor. Atomic force microscopy
measurements did not show an increase of the effective membrane tension, such that clustering of the receptor
remains the likely mechanism for its reduced mobility. ii) The receptor got frequently stalled for longer periods of
multiple seconds, which may signal the first step of the internalization process.
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Introduction
The epidermal growth factor receptor (EGFR) is one of the
best-characterized receptor (protein) tyrosine kinases in
endocytic trafficking. This transmembrane receptor has a key
role in organ morphogenesis, maintenance and repair. EGFR is
also involved in various cancers by contributing to malignancy
due to over-expression or oncogenic mutations [1]. Thus EGFR
is a target for therapeutic intervention in different cancer
treatments [2]. Endocytic trafficking and signalling of EGFR, as
well as of other signalling receptors, are tightly intertwined [3,4]
and cancerous cells take advantage of such a functional link to
enhance the oncogenic influence of EGFR [5]. This motivates
research to increase our understanding of these processes at
the molecular level.
For a long time the spatiotemporal dynamics of EGFR at the
cell surface, before its internalization have been attracting great
interest [6] but still remain incompletely understood. A single
EGFR on the plasma membrane binds EGF to form a pre-
signalling state after which a second EGFR binds forming a
homo-dimer with the first one. Although experimental evidence
for EGFRs in solution is consistent with a ligand-induced
allosteric dimerization model [6], there is increasing evidence
that cell surface EGFR activation depends on conformational
changes within preformed dimers, interactions between
receptor dimers, heterodimerization, cross-talk with other
receptor types, and ligand-independent lateral propagation of
the activation processes, [7,8]. Single molecule studies have
also identified a signal amplification mechanism involving the
dynamic clustering of the EGFR [9]. The dimer becomes then
auto-phosphorylated and later internalized. This starts the
signalling cascade [8,10].
Since EGFR has a key role in cancer, it is important to
understand how drugs affect the availability and functionality of
EGFR in the cell membrane. In this study we focus on
propranolol, an inhibitor of phosphatidic acid (PA)
phosphohydrolase activity, which leads to increased PA levels
in the cell [11-13]. Although propranolol does not interact with
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EGFR directly, it leads to an accumulation of PA accompanied
by a stimulation of type 4 phosphodiesterases (PDE4) and a
significant decrease in both cAMP levels and protein kinase-A
(PKA) activity. This provokes a reversible redistribution of
empty EGFR from the cell surface to recycling endosomes
through PA-mediated signalling toward the PDE4/cAMP/PKA
pathway, thus reducing the receptor accessibility for external
stimuli [14,15]. Both clathrin-dependent and clathrin-
independent pathways seem to be involved in this PA-
mediated pathway [16]. The molecular mechanisms that
underlie such receptor internalization under propranolol
treatment remain unknown.
In order to obtain more insight in the events that precede the
internalization process we investigated if propranolol affects the
mobility of the receptors before they get internalized. The two
extreme behaviours that are expected are the unhindered
diffusion of the receptor along the cell membrane, and the
receptor getting stuck at a fixed location. In addition, any
intermediate behaviour, showing a combination of both, can
occur when the receptor is hindered in its motion. Either by
binding partners or aggregates in the lipid bilayer [17], or by
interaction with protein networks such as the f-actin or clathrin
[18,19].
To be able to follow the sequence of events of individual
EGFR we tracked the motion of single fluorescently labelled
receptors while they moved along the cell surface. As label we
used quantum dots (QD) that were coupled to the EGFR
antibodies. QDs are nanometre sized semiconductors that,
similar to conventional fluorophores, can emit photons upon
being exited with light. In contrast to conventional fluorophores,
QDs have a higher photo-stability, which makes them ideal
probes for long-term single particle tracking and time-lapse-
microscopy [20]. Quantum dots do however occasionally blink
[21] which can complicate single particle tracking in a densely
labelled environment. To avoid this, we labelled only a subset
of EGFR.
To obtain a fluorescent signal only from the cell periphery we
used total internal reflection fluorescence (TIRF) microscopy. In
this technique the excitation light does not enter into the
sample but is reflected off the coverslip. At the coverslip-buffer
interface an evanescent wave will penetrate into the sample for
about 200 nm [22]. Thus only fluorophores that are close to the
coverslip are excited and background fluorescence coming
from within the cell is largely avoided.
We observed that the mobility of EGFR is dominated by
rapid alternations between diffusive and non-diffusive, which
originates from a stop-and-go motion of the receptor. In the
presence of propranolol we did observe a significant reduction
in the average diffusion constant, but no increase in the stop-
and-go ratio. We performed atomic force microscopy (AFM)
measurements to exclude the possibility that the reduced
receptor mobility was caused by an increase of the rigidity of
the membrane or its interaction with the cell cortex [23]. Also
we found that propranolol eventually induced stalling of EGFR
for multiple seconds, which we speculate to be the preparing
step for the respective drug induced endocytosis.
Results
To be able to perform single molecule tracking experiments
we constructed an inverted microscope around a commercial
TIRF microscope objective. Due to its minimal and rigid design
(Figure 1) this instrument offers a low focus drift which is
required for observation times of minutes at diffraction limited
performance. An additional benefit of this simple design is that
the building costs are mainly determined by the TIRF objective
and EM-CCD camera. The total cost of approximately 30.000
euro shows that single molecule tracking experiments are also
within reach for laboratories with a limited budget. To be able to
administer drugs during imaging we used an open-top sample
chamber. The coverslip containing the cells was glued under a
microscope slide that had a 1 cm diameter opening cut out
(see methods and inset Figure 1A).
To follow the response of single EGFR upon the addition of
propranolol we used a single molecule tracking approach. A
small fraction of individual EGFR molecules was tagged with a
conjugate of one QD linked to one anti-EGFR antibody Fab
fragment. In [24] it was shown that this QD conjugate had no
effect on the EGF induced phosphorylation of the receptor thus
suggesting an unperturbed receptor function. Because of the
use of single Fab fragments (instead of whole antibodies) the
QD conjugate is not expected to induce dimerization of EGFR,
which makes this an ideal method to study the dimerization of
monomeric receptors [24,25]. Single labelled EGFRs could be
imaged by our TIRF microscope at high signal to noise ratio
(Figure 2a and b). The motion of the QDs was quantified using
a tracking algorithm based on the centre of intensity algorithm
[26] (see methods).
We have monitored the squared displacements (SD)
between successive frames and summed these to obtain the
cumulative square distance (CSD) as function of the time.
Basically the total length of the sampled path of the QD is thus
quantified. The advantage of this approach, as compared to the
mean square distance (MSD, which shows the squared
distance from the starting point), is that the CSD is not affected
by boundary conditions that could limit the area available for
diffusion. As result the CSD gives a good estimate for the
average diffusion coefficient and largely ignores effects of
spatial constraints of the diffusion area. Figure 2 (c and d)
shows typical paths of single receptor diffusion obtained via
this tracking routine. Figure 2 e and f show the individual
(squared) displacements between frames (grey circles). The
respective CSD curves are represented in green in Figure 2 (e
and f).
To test if propranolol had an effect on the average diffusion
constant, HeLa cells were incubated with or without
propranolol, and the motion of single EGFR was quantified as
described above. Figure 3 shows the averaged CSD plots for a
total of 92 particles that were measured in 11 different
experiments. We found a 22 % reduction of the diffusion
coefficient when propranolol was added: Dcontrol= 0.077 µm2/s
and Dpropranolol= 0.060 µm2/s.
When looking at the individual SD-steps such as shown in
Figure 2 (e and f, grey circles), it appears that many of these
SD-steps were nearly zero whereas others showed relative
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large steps. In presence of propranolol the same phenomenon
is visible, which leads to the question if EGFR exists in two
states, a slow one and a fast one. When two distinct diffusion
constants are present then one would also expect to see two
populations when all step-sizes between successive frames of
all curves are plotted in a histogram. Figure 4 shows, indeed,
Figure 1.  Minimal design inverted TIRF microscope.  a) A
photograph of the instrument, the view on the objective is
hidden by the x-y sample stage. The inset cartoon shows the
open-top sample chamber.
b) A cross-sectional drawing of the essential components of the
instrument. The TIRF objective is mounted on a flexure z-stage
to adjust the focus. The image is directed via a mirror and tube-
lens onto an EM-CCD camera. The excitation laser light comes
from a single-mode optical fibre and is coupled into the optical
path via a dichroic mirror. The TIRF angle is adjusted by
adjusting the angle of the second mirror that is placed in a
plane that is conjugate to the back focal plane of the objective.
The sample is mounted on a mechanical xy stage and
illuminated from top via a small illumination tower that is set-up
according to the Köhler illumination scheme.
doi: 10.1371/journal.pone.0083086.g001
clearly 2 peaks in the histograms. From the comparison with
the step-size histogram from immobilized quantum dots, it
becomes obvious that the first peak corresponds to particles
that are almost stationary. Only the second peak shows the
actual diffusive behaviour. For the experiments with propranolol
this second peak is shifted towards a lower step-size as
compared to the control experiments, consistent with the
reduced average diffusion constant as shown in Figure 3.
The presence of two clearly distinguished peaks in the EGFR
step-size histograms indicates that the receptors can exist in
both a mobile and a semi-stationary state. These states exist
both with and without propranolol. An investigation of all
individual CSD tracks, such as shown in Figure 2 (E and F,
Figure 2.  Tracking single EGFR.  a) The bright-field and b)
fluorescence image of two cells. On the cells typically multiple
mobile QDs were visible. The coverslip is covered with
immobilized QDs.
c, d) Two typical trajectories of single EGFR recorded over one
minute.
e, f) The corresponding SD/CSD-plots. The SD steps between
successive frames are shown in grey and the cumulative plot in
green. In some curves apparent changes in slope could be
observed (c), but the majority of CSD plots looked like (d)
without obvious variations in slope.
doi: 10.1371/journal.pone.0083086.g002
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green curve) did not reveal an obvious separation of stationary
and mobile phases; the stationary phases last typically only
between 1 and 5 frames. From this we conclude that the
stationary states have only a very short lifetime, on the order of
100 ms. Physically, this can be understood by EGFR getting
stuck continuously, but only for short amounts of time. This
possibility is included in the cell membrane ’picket’-model
[7,27].
Since we obtained the average diffusion constant by a fit to
the CSD plots (Figure 3) this includes also the short lived
sticking events which leads to an underestimation of the
unrestricted diffusion speed. To obtain an estimate of the
diffusion speed when the receptors are not hindered in their
motion, we fitted a probability density function to the
histograms of Figure 4 (see methods). From the 'fast' step-size
peaks this gives a diffusion coefficient of: Dcontrol = 0.11 µm2/s
and Dpropanolol = 0.084 µm2/s (table 1). The 24 % reduction of
the diffusion coefficient in the presence of propranolol is
identical with the observed reduction of the average diffusion
coefficient measured with the CSD. Because the ratio between
both peaks remains almost similar, propranolol mainly reduces
the actual unrestricted diffusion speed but it does not increase
the time the receptor spends in the semi-stationary phase.
The reduction of the unrestricted diffusion coefficient in
presence of propranolol can be caused by dimerization or
clustering of EGFR but also by an increased rigidity of the
plasma membrane. To test for changes in the composition of
the plasma membrane or the underlying cell cortex we
measured the effective membrane tension in absence and
presence of propranolol. This was performed by extracting
Figure 3.  Average CSD plots with and without
propranolol.  A total of 92 individual EGFR tracks of at least 1
minute were used to calculate the average CSD curves. The
average diffusion coefficient was obtained by a linear fit to the
curves and give for Dcontrol= 0.077 ± 0.002 µm2/s and
Dpropranolol= 0.060 ± 0.002 µm2/s (mean ± s.e.m.). To obtain
the s.e.m., the CSD of each individual track was fitted. The
s.e.m. was calculated from these individual fits.
doi: 10.1371/journal.pone.0083086.g003
membrane tethers from the cell by AFM pulling experiments
(inset Figure 5). The force that is required to extract a
membrane tether depends on the membrane bending rigidity
and on the interaction of the membrane with the cell cortex
[28]. Such tether extraction measurements have been
successfully applied to measure the effects of compounds like
cholesterol and Latrunculin-A on the effective membrane
tension [29,30]. Figure 5 shows that the tether force without
propranolol (28.26 ± 0.83 pN) remains unaffected after the
addition of propranolol (28.92 ± 1.02 pN). Propranolol does not
induce measurable changes in the mechanical organization of
the cell cortex and plasma membrane which could hinder the
mobility of EGFR.
Before, we showed that diffusive tracks of EGFR are a
continuous alternation of stop-and-go motion. The addition of
Figure 4.  Step-size distribution with and without
propranolol.  The histograms include all individual
displacements (steps) between the successive frames of all
tracked EGFR without (yellow) and with propranolol (green).
The coloured histograms each show two peaks, representing
two populations of step-sizes. Control experiments performed
with immobilized QDs (grey) shows that the first peak
represents particles that are almost stationary, the second
peak shows the actual diffusive motion. The ratio between the
areas of both peaks remains almost identical with and without
propranolol. In presence of propranolol the diffusive peak has
clearly shifted to lower step-sizes.
doi: 10.1371/journal.pone.0083086.g004
Table 1. The fitted parameters (± s.d. of the fit) for equation
1 for the different step-size histograms.
 C D, slow D, fast
control 0.240 ± 0.007 0.0073 ± 0.0003 0.110 ± 0.002
propranolol 0.204 ± 0.004 0.0102 ± 0.0003 0.0835 ± 0.0009
doi: 10.1371/journal.pone.0083086.t001
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propranolol leads to a small, but significant reduction of the
mobility of EGFR along the membrane. As next step we expect
that propranolol induces the internalization of the receptor [15].
In order to investigate this on a single receptor level, we
screened all CSD plots for longer pauses in mobility. Figure 6
shows an example of a receptor that suddenly got stalled in
presence of propranolol. In 6 out of 38 measurements that
were performed in presence of propranolol the QD stopped and
stayed stationary for at least 10 s (in 5 different experiments
and cells). In 4 cases, EGFR continued its motion after the
stationary phase. Without propranolol, such stalling was never
observed (n = 54). We speculate that this stalling represents
the first step in the propranolol induced internalization pathway.
Complete internalization, which should show as a
disappearance of the QD, was never observed and might have
been prevented by the relative large dimensions of the QD (≈
10 nm diameter).
Discussion
EGFR has been intensively studied, principally due to its
participation in controlling fundamental cellular functions and its
role in cancer development. In the absence of EGF propranolol
indirectly induces the internalization of EGFR in a dose-time
dependent manner [15]. This makes propranolol a highly
interesting alternative to control EGFR functioning by lowering
the number of the available receptors on the cell surface.
To gain a better understanding of the events that eventually
lead to the internalization process, we studied the effects of
propranolol on the mobility of EGFR before the actual
internalization took place. By monitoring the mobility of the
Figure 5.  Propranolol does not affect the effective
membrane tension.  A total of 333 membrane tethers were
pulled off 23 different cells, on 5 different cover slips using 4
different AFM cantilevers. The tether force is around 28 pN
without a statistical relevant difference with and without
propranolol. Inset) To measure the effective membrane tension
an AFM tip was brought in contact with the cell and then pulled
away. The rupture of the extracted membrane from the tip is
visible as a sudden jump to zero force.
doi: 10.1371/journal.pone.0083086.g005
EGFR along the membrane the effects of propranolol on the
interaction of the receptor with the cell cortex and other binding
partners and its tendency to aggregate in larger assemblies
can be studied. Using single particle tracking of EGFR in HeLa
cells we surprisingly found, both with and without the drug, that
the receptor shows a pronounced stop-and-go motion; the
diffusive path was continuously interrupted by short pauses
that lasted for just a few frames. A similar phenomenon was
described for EGFR in human epithelial cells [31], who
attributed the pauses to the receptor getting stuck in 'nano-
domains'. Because our analysis shows that the step-size of the
semi-stationary phase is close to that of fixed QDs, this argues
for a domain with a very low diffusion coefficient itself (D ≈ 0.01
µm2/s, table 1). It has been shown that receptors can be
transiently trapped by the actin cytoskeleton or by lipid rafts
[32], and EGFR was recently reported to form transient clusters
on the cell membrane [27]. Trapping of EGFR to clusters is
consistent with our observations; the first peak corresponds to
the occasional sticking of the observed protein to the cluster
and the second peak belongs to the actual diffusion through
the membrane between such clusters. In our measurements
this clustering accounts for ≈ 20 % of all events and therefore
leads to an underestimation of the unrestricted diffusion
coefficient.
In HeLa cells, we calculate an average diffusion coefficient
for EGFR monomers of Dcontrol = 0.077 µm2/s, which is
comparable with values that were reported for EGFR
[24,33,34]. Lipids in a synthetic bilayer move with 3.0 µm2/s
considerably faster [35]. This difference is partly explained by
the pauses that are present in the diffusive tracks of EGFR,
and also by the larger drag coefficient of the receptor as
compared to a lipid. Under the assumption that the diffusivity in
membranes follows the Stokes-Einstein relationship the drag of
the lipid or receptor should scale with the inverse of its mobility
[36].
In a recent study temporal changes in the diffusion
coefficient of single EGFR were used to follow the dynamics of
Figure 6.  Propranol induces stalling of EGFR.  a) Trajectory
of an EGFR after propranolol treatment. After some time the
receptor got stuck and remained at one location (indicated in
blue).
b) The same trajectory plotted against time. The stationary part
(blue) is clearly distinguishable. After being stationary for
almost 40 s the receptor continued its travel again.
doi: 10.1371/journal.pone.0083086.g006
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dimerization of EGFR [24]. Since dimerization increases the
drag on the receptor, it may be possible to distinguish between
monomer and dimer states by a difference in their diffusion
constant. Indeed, Chung et al. showed within single diffusive
tracks a two-fold change of diffusion constant, which they
attributed to monomer-dimer transitions of EGFR. Another
recent study, where two different coloured labels were used to
directly show receptor dimerization, showed however that the
dimerization cannot be simply deduced from a temporal
change in the diffusion coefficient [25]. In our experiments we
also tried to use the change of the diffusion coefficient as an
indicator to screen the effects of propranolol on the
dimerization rate of EGFR. Despite using similar techniques as
in [24] we could not unambiguously observe dimerization
events in single diffusive tracks. Although some of our CSD
curves (like Figure 2e) show apparent changes in slope during
diffusion, the majority of the curves looked like Figure 2f,
without obvious transitions between two slopes. The stop-and-
go motion of the receptor may be one of the reasons why it is
very difficult to use the diffusion coefficient as a sole marker to
distinguish monomers from dimers, but also the histogram
(Figure 4) shows the presence of only a single mobile
population.
The main goal of this study was to test if propranolol affected
the mobility of single EGFR before internalization in the
absence of ligand. In all cases the mobility of EGFR was
dominated by a stop-and-go motion. In presence of the drug
we found two effects. The first effect was a 22 % reduction of
the average diffusion constant. This reduction is mainly caused
by the reduction of the unrestricted diffusion coefficient and not
by an increase of the number, or duration, of the pauses. The
short pauses show transient sticking or clustering of EGFR and
are not affected by propranolol. The reduction of the
unrestricted diffusion coefficient can be explained by an
increased drag of EGFR through the membrane. From AFM
membrane tether extraction experiments we could exclude an
increase of the membrane bending rigidity or the membrane
interaction with the cell cortex. This suggests that the reduced
diffusion coefficient is caused by the binding of EGFR to other
binding partners or by clustering of the receptor. The latter
option is supported by the finding of Ariotti et al. who reported
that the addition of exogenous PA leads to clustering of EGFR
[37]. To identify the exact nature of the interactions of EGFR,
labelling experiments in which the various possible partners are
tagged with different colours will be helpful to identify the
players that are involved in regulating the mobility of EGFR. As
a second effect of propranolol we found that the receptor gets
frequently stalled for longer periods of multiple seconds. This
inhibited mobility of the receptor upon drug treatment may
signal the entering of the receptor on an endocytic platform, a
first step of the internalization process that will lead to the drug
induced endocytosis.
Materials and Methods
TIRF microscopy
TIRF imaging was performed on a custom built inverted
microscope. All opto-mechanical parts were purchased from
Thorlabs GmbH (Germany), except for the following items. The
xy stage (Märzhäuser Wetzlar GmbH, Germany) and the
PLAPON 60x 1.45NA objective (Olympus, Japan). The sample
was illuminated by coupling in a single mode fibre with an
output power of 2 mW at 488 nm (Nichia, Japan). The light
from the fibre was collimated and then focussed on the back
focal plane of the objective using a 100 mm focal length lens.
The laser was coupled in the optical path via a dichroic mirror
(Di01-R488, Semrock, Rochester, NY, USA) that was placed
under the objective. To be able to change the angle of the laser
beam coming from the objective, a mirror was placed 100 mm
before the laser-focussing lens. Thus a tilting of the mirror
results in a lateral translation of the beam in the back focal
plane of the objective. The light from the objective was passed
through two emission filters in series (595/50 and 630/75;
centre wavelength/width) and focussed with a 75 mm focal
length tube lens onto an EM-CCD camera (Luca-S, Andor,
Ireland), which resulted in a total magnification of 205 nm per
pixel. All movies were recorded at a frame rate of 20 Hz. The
experiments were carried out at room temperature (25°C).
Open-top sample holder
To facilitate the addition of propranolol containing medium
before the experiments we used a simple open-top sample
chamber. The microscope coverslip containing the cells was
glued using grease (Apiezon-H, M&I Materials Ltd., UK) onto a
microscope slide that had a 10 mm aperture cut out (inset
Figure 1A). During the assembly, the cells were kept under
medium at all times. The opening in the microscope slide was
made using a small sand-blasting device (Renfert GmbH,
Germany), after each experiment the slides were cleaned to be
reused.
Preparation of Fab-QDs and tagging single EGFR with
the conjugate
To avoid receptor dimerization by the anti-EGFR antibody,
only the isolated Fab fragments were used. EGFR–Fab-biotin
was produced by pepsin digestion of an anti-EGFR IgG
(AB-11; clone 199.12, LabVision) followed by reduction of the
resulting F(ab')2 to yield a Fab fragment which binds
specifically to the EGFR ectodomain 12–14. The Fab was then
conjugated with biotin through the unique -SH at its carboxy-
terminal. To prepare anti-EGFR–Fab-QD conjugates, 1 ml of a
solution of 0.7 nM anti-EGFR–Fab-biotin in DMEM was added
drop-wise to 1 ml of 2 nM QDs coated with streptavidin (CdSe,
QD605, Invitrogen). Thus, on average every QD carried less
than 1 anti-EGFR–Fab-biotin. QD605 are exited at 488 nm
wavelength and emit photons of lower energy at ≈ 605 nm.
Cells
HeLa cells (250.000 cells) were cultured on glass coverslips.
Cell monolayers (70% confluent) were serum starved for 2
hours before being incubated with 500 µl of the final anti
EGFR–Fab-QD solution at 25 °C for 2 min. Cells were then
washed twice with PBS at 25 °C, placed in serum-free medium
(DMEM + 25 mM Hepes pH 7.4), and mounted into the sample
holder. For the experiments in presence of the drug, 150 mM of
propranolol was present in the serum-free medium.
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Tracking algorithm
To determine the position of single QDs with sub-pixel
accuracy, the centre of the imaged spot had to determined. To
estimate the centre of the point spread function we used a 2D-
Centroid algorithm similar to the one described by 26.
Basically, the centre of intensity in a pre-selected region in the
image is calculated. The routine was written as a plug-in for
ImageJ and performed the following steps:
1 Select a QD in the first frame and select a 2 x 2 µm region
around it, which does not contain any other QDs
2 Proceed to next frame, calculate the new centre of intensity
and re-centre the selected region.
3 Repeat step 2 until last frame.
Fitting of the diffusion step-size histogram
To obtain an estimate for the unrestricted diffusion coefficient
of the receptor we fitted a probability density function (eq. 1) to
the step-size histogram (see table 1 for the fit values). The first
peak we attribute to the semi-stationary 'slow' QDs, and the
second peak to the unrestricted 'fast' moving QDs. Both peaks
are fitted with a step-size distribution of a 2D diffusion process
[38]. Dslow and Dfast are the diffusion coefficients of the
respective peaks, x the step-size and Δt is the time between
frames (0.05 s). C gives the proportional contribution of the
semi-stationary QDs to the histogram. Before fitting, the total
surface area of the histograms was set to 1 by rescaling the
height of the bars.
PDF(x) =C* x2DslowΔt exp −
x2
4DslowΔt
'slow' peak
+ (1−C)* x2D f astΔt exp −
x2
4D f astΔt
'fast' peak
(1)
Atomic force microscopy
The membrane tether extraction measurements were
performed on an Asylum MFP3D AFM (Asylum Research, CA,
USA) that was placed onto a bright-field illuminated inverted
optical microscope equipped with a 60x 1.49 N.A. objective.
First, a cell was selected with the optical microscope and the
AFM tip was positioned above the cell body but away from the
nucleus. Then the tip was brought down to touch the cell at a
force of 0.3 nN. After 2 seconds the tip was pulled away for a
distance of 8 µm at a relatively low pulling speed of 1 µm/s. In
about 50% of all curves a membrane tether was pulled off the
cell by the AFM tip, which was visible as constant force plateau
when the tip was retracted. Most tethers could not be extracted
for the full 8 µm but ruptured, which is visible in the force
curves as a sudden jump to zero force (inset Figure 5). To
obtain the tether force we analysed only those curves in which
the force before and after the rupture event was constant for at
least 500 nm of pulling. The tether force was quantified by the
difference of the average force of the 500 nm before and of the
500 nm after the rupture. For the experiments we used soft
cantilevers (BL150, 30 x 60 µm, Olympus, Japan) with a
calibrated spring constant of ≈ 0.03 N/m. To minimize the
effects of calibration errors we used 4 different cantilevers,
each of which for both the control and the experiments with
propranolol. The experiments were performed at 24°C.
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